Frequently Asked Questions

Frequently Asked Questions About Clinical Trials (FAQ)

A clinical trial is a carefully-designed study that is done with volunteers who receive investigational medical treatments. The volunteers are under close watch from doctors and research professionals. The treatments are developed by pharmaceutical companies who select physicians to conduct the trials. Through these trials, the benefits of investigational drugs may be shown.
Once you have enrolled in a clinical trial (also known as a study), you may receive a physical examination.  Your study doctor or a research staff member will also review your medical history. A detailed description of your specific clinical trial and what’s to be expected of you will be outlined in an informed consent form. Your safety and privacy are always a priority.
Informed consent means that study volunteers understand the details of their clinical study before agreeing to participate. Participants must be provided with all the facts about a study, including treatment details and possible risks and benefits. They must sign an informed consent form before they participate. In addition, participants must be kept informed of any changes that could affect them during  the clinical trial.
Phase 1 studies typically last between one and two weeks. Phase 2, Phase 3, and Phase 4 studies can last several months to several years. In most studies, in-person visits to our center are required.
Clinical trials are conducted in phases. The trials at each phase have a different purpose and help answer different questions:

In Phase I trials, researchers give a drug or treatment under study to a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.

In Phase II trials, the experimental study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to evaluate its safety.

In Phase III trials, the experimental study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and to evaluate it’s safety.

In Phase IV trials, post marketing studies seek additional information including the drug’s risks, benefits, and optimal use.

At Albuquerque Clinical Trials, we value our sponsors and strive to deliver the best results. We owe new advancements in the medical field to the sponsor. Our team is dedicated to professionalism and accuracy, from recruiting volunteers to participants to delivering data. Our research site emphasizes training and knowledge under operating procedures typically seen at much larger institutions.
After a study is complete, all of the information is collected and analyzed. This information determines whether a study drug is working, safe, and if it has any side effects. FDA medical advisers and specialists closely review this data before approving any new drug.